OFD1

Across TCGA pan-cancer cohorts, OFD1 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OFD1’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where OFD1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types OFD1 is over-expressed in tumor, although a few such as PDAC and COAD show the opposite, repressed pattern.

CCRCC, PDAC, and COAD are the cancer types where OFD1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OFD1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	All	All	+0.111	<.001	7	view →
PDAC	All	II,III,IV	−0.416	<.001	6	view →
COAD	All	All	−1.418	.026	4	view →
LSCC	All	II,III,IV	−0.123	<.001	4	view →
OV	All	All	−0.546	.040	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OFD1–CCRCC

Open the CCRCC breakdown →